These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 408657)

  • 1. [The treatment of metastasizing hypernephroid (renal cell) carcinoma with medroxyprogesterone acetate (Clinovir) (author's transl].
    von Lieven H; Hahn D
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1089-92. PubMed ID: 408657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
    Kjaer M; Frederiksen PL
    Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
    Balogh F; Romics I
    Z Urol Nephrol; 1987 Aug; 80(8):449-53. PubMed ID: 2961162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
    König HJ; Hartwich G
    Dtsch Med Wochenschr; 1980 Dec; 105(52):1810-4. PubMed ID: 7449648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
    Katakkar SB; Franks CR
    Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinovir treatment of adenocarcinoma of the uterus with lung metastases].
    Stertmann WA; Hocke M; Röttger P
    MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):685-6. PubMed ID: 6225946
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regressions of pulmonary metastases of clear cell carcinoma after nephrectomy and progestogen therapy].
    Frea B; Tizzani A; Tasso M
    Minerva Urol; 1981; 33(2):97-101. PubMed ID: 7322102
    [No Abstract]   [Full Text] [Related]  

  • 8. [Maintenance chemotherapy for ovarian adenocarcinoma with carboquone: doses and side effects (author's transl)].
    Sekiya S; Iwasawa H; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):634-6. PubMed ID: 6282997
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
    Tomic R; Ljungberg B; Damber JE
    Scand J Urol Nephrol Suppl; 1988; 110():185-7. PubMed ID: 2973122
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic tests in the prognosis and course controls in bronchial carcinoma patients.
    Dallüge KH; Ziegenbein R
    Arch Geschwulstforsch; 1982 May; 52(3):199-202. PubMed ID: 7125855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The activity of transaminases (GOT and GPT), alkaline phosphatase and gamma-glutamyl transferases in the serum of patients treated with Rifampicin (author's transl)].
    Krstić-Burić M; Arko K; Rusan A; Mance D
    Plucne Bolesti Tuberk; 1980; 32(3):132-8. PubMed ID: 6110213
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of high-dose medroxyprogesterone treatment given for endometrial carcinoma on carbohydrate metabolism and liver function.
    Ylöstalo P; Vehaskari A; Kauppila A; Sotaniemi E
    Ann Chir Gynaecol Fenn; 1974; 63(2):93-8. PubMed ID: 4851752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of renal cell carcinoma. 1. Hormonal therapy].
    Kobayashi M; Imai K; Nakai K; Suzuki T; Nagata M; Ito Y; Yamanaka H
    Hinyokika Kiyo; 1985 Sep; 31(9):1531-7. PubMed ID: 2417463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.
    Paine CH; Wright FW; Ellis F
    Br J Cancer; 1970 Jun; 24(2):277-82. PubMed ID: 5451569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medroxyprogesterone acetate contraception on human serum enzymes.
    Mukherjea M; Mukherjee P; Biswas R; Chakraborty AS; Kushari J
    Int J Fertil; 1981; 26(1):35-9. PubMed ID: 6113206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone receptors and endocrine therapy of renal carcinoma].
    Pizzocaro G; Piva L; Di Fronzo G; Ronchi E; Giongo A; Cozzoli A; Dormia E; Minervini S; Zanollo A; Fontanella U
    Ric Clin Lab; 1985; 15 Suppl 2():95-102. PubMed ID: 2937131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of metastasizing carcinoma of the uterus with gestagens].
    Engeler V
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative assessment for hepatic metastases in carcinoma of the colon and rectum.
    Ranson JH; Adams PX; Localio SA
    Surg Gynecol Obstet; 1973 Sep; 137(3):435-8. PubMed ID: 4721514
    [No Abstract]   [Full Text] [Related]  

  • 19. [the oral use of a progestational hormone (Provera 100) as an adjuvant in therapy of adenocarcinoma of the kidney. Preliminary report].
    Liberti M; Di Silverio F; Concolino G; Tenaglia R; Marocchi A
    Minerva Urol; 1980; 32(3):175-8. PubMed ID: 7432332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.